Evidence map›Paper›PMID 35874450›Full record

ArticleJournal of clinical tuberculosis and other mycobacterial diseases2022

Adaptations to the first wave of the COVID-19 pandemic by private sector tuberculosis care providers in India.

Shamim Mannan, Charity Oga-Omenka, Akhil Soman ThekkePurakkal, Lavanya Huria, Aakshi Kalra, Ravdeep Gandhi, Tunisha Kapoor, Nathali Gunawardena, Shekhar Raj, Manjot Kaur and 9 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical tuberculosis and other mycobacterial diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. COVID-19 policies and tuberculosis services in private health sectors of India, Indonesia, and Nigeria.Journal of clinical tuberculosis and other mycobacterial diseases · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Implementation of a tuberculosis elimination project, India 2018-2019.Bulletin of the World Health Organization · 2023
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Shamim MannanClinton Health Access Initiative (CHAI), India.
Charity Oga-OmenkaMcGill International TB Centre, Montreal, Canada.
Akhil Soman ThekkePurakkalFoundation for Innovative New Diagnostics (FIND), India.
Lavanya HuriaMcGill International TB Centre, Montreal, Canada.
Aakshi KalraFoundation for Innovative New Diagnostics (FIND), India.
Ravdeep GandhiPATH, India.
Tunisha KapoorClinton Health Access Initiative (CHAI), India.
Nathali GunawardenaDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada.
Shekhar RajCentre for Health Research and Innovation (CHRI), India.
Manjot KaurTB PPM Learning Network, Research Institute of the McGill University Health Centre, Canada.
Angelina SassiMcGill International TB Centre, Montreal, Canada.
Tripti PandeMcGill International TB Centre, Montreal, Canada.
Vijayan ShibuPATH, India.
Sanjay SarinFoundation for Innovative New Diagnostics (FIND), India.
Sarabjit Singh ChadhaFoundation for Innovative New Diagnostics (FIND), India.
Petra HeitkampMcGill International TB Centre, Montreal, Canada.
Jishnu DasMcCourt School of Public Policy, Georgetown University, Washington, DC, USA.
Raghuram RaoCentral TB Division, Ministry of Health & Family Welfare, India.
Madhukar PaiMcGill International TB Centre, Montreal, Canada.
McGill University · CAMcGill University Health Centre · CAProgram for Appropriate Technology in Health · INGeorgetown University · USMinistry of Health and Family Welfare · INUniversity of Waterloo · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: India's dominant private healthcare sector is the destination for 60-85% of initial tuberculosis care-seeking. The COVID-19 pandemic in India drastically affected TB case notifications in the first half of 2020. In this survey, we assessed the impact of the first wave of COVID-19 in India on private providers, and changes they adopted in their practice due to the pandemic. Methods: The Joint Effort for Elimination of TB (JEET) is a nationwide Global Fund project implemented across 406 districts in 23 states to extend quality TB services to patients seeking care in private sector. We conducted a rapid survey of 11% (2,750) of active providers engaged under JEET's intense Patient Provider Support Agency (PPSA) model across 15 Indian states in Q1 (February-March) of 2021. Providers were contacted in person or telephonically, and consenting participants were interviewed using a web-based survey tool. Responses from participants were elicited on their practice before COVID-19, during the 2020 lockdowns (March-April 2020) and currently (Q1 2021). Data were adjusted for survey design and non-response, and results were summarised using descriptive statistics and logistic regression. Results: Of the 2,750 providers sampled, 2,011 consented and were surveyed (73 % response). Nearly 50 % were between 30 and 45 years of age, and 51 % were from Uttar Pradesh, Maharashtra and Gujarat. Seventy percent of providers reported reduced daily out-patient numbers in Q1 2021 compared to pre-COVID times. During the lockdown, 898 (40 %) of providers said their facilities were closed, while 323 (11 %) offered limited services including teleconsultation. In Q1 2021, 88 % of provider facilities were fully open, with 10 % providing adjusted services, and 4 % using teleconsultation. Only 2 % remained completely closed. Majority of the providers (92 %) reported not experiencing any delays in TB testing in Q1 2021 compared to pre-COVID times. Only 6 % reported raising costs at their clinic, mostly to cover personal protective equipment (PPE) and other infection control measures, although 60-90 % implemented various infection control measures. Thirty-three percent of TB providers were ordering COVID-19 testing, in addition to TB testing.To adapt, 82% of survey providers implemented social distancing and increased timing between appointments and 83% started conducting temperature checks, with variation by state and provider type, while 89% adopted additional sanitation measures in their facilities. Furthermore, 62% of providers started using PPE, and 13% made physical changes (air filters, isolation of patient areas) to their clinic to prevent infection. Seventy percent of providers stated that infection control measures could decrease TB transmission. Conclusion: Although COVID-19 restrictions resulted in significant declines in patient turn-out at private facilities, our analysis showed that most providers were open and costs for TB care remained mostly the same in Q1 2021. As result of the COVID-19 pandemic, several positive strategies have been adapted by the private sector TB care providers. Since the subsequent COVID-19 waves were more severe or widespread, additional work is needed to assess the impact of the pandemic on the private health sector.

Indexed as

AdaptationsCOVIDDiagnosis and treatmentHealthcare deliveryIndiaPrivate sector providersTB

Identifiers

PMID35874450
PMCPMC9295336
OpenAlexW4286249414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.